Skip to main content

Table 1 Characteristics of 276 non-diabetic control subjects.

From: Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases

 

Total

Males

Females

p

n (%)

276 (100)

110 (39.9)

166 (60.1)

 

Age (years ± SEM)

38.9 ± 0.9

38.5 ± 1.5

39 ± 1.0

n.s.

BMI (kg/m2 ± SEM)

27.9 ± 0.4

27.8 ± 0.6

28.1 ± 0.6

n.s.

Cholesterol, total (mg/dl ± SEM)

221 ± 3

220 ± 5

223 ± 4

n.s.

HDL-cholesterol (mg/dl ± SEM)

58 ± 1

50 ± 2

62 ± 2

p < 0.0001

LDL-cholesterol (mg/dl ± SEM)

133 ± 3

130 ± 5

134 ± 3

n.s.

Triglycerides (mg/dl ± SEM)

168 ± 15

199 ± 23

151 ± 21

p = 0.03

Uric acid (mg/dl ± SEM)

5.7 ± 0.1

6.8 ± 0.1

4.9 ± 0.1

p < 0.0001

  1. SEM = standard error of the mean, n.s. = not significant